Home/Filings/4/0001245071-10-000012
4//SEC Filing

FOLLIS DANIEL S 4

Accession 0001245071-10-000012

CIK 0000704328other

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 1:13 PM ET

Size

18.2 KB

Accession

0001245071-10-000012

Insider Transaction Report

Form 4
Period: 2010-07-27
Transactions
  • Disposition from Tender

    Common Shares

    2010-07-27$25.00/sh8,270$206,7500 total(indirect: By Partnership)
  • Disposition to Issuer

    Director stock option (right to buy)

    2010-07-27$10.23/sh10,000$102,3000 total
    Exercise: $14.77Exp: 2019-04-23Common Shares (10,000 underlying)
  • Disposition to Issuer

    Director stock option (right to buy)

    2010-07-27$5.67/sh10,000$56,7000 total
    Exercise: $19.33Exp: 2017-06-13Common Shares (10,000 underlying)
  • Disposition from Tender

    Common Shares

    2010-07-27$25.00/sh9,300$232,5000 total
  • Disposition to Issuer

    Director stock option (right to buy)

    2010-07-27$8.18/sh10,000$81,8000 total
    Exercise: $16.82Exp: 2018-04-10Common Shares (10,000 underlying)
  • Disposition to Issuer

    Director stock option (right to buy)

    2010-07-27$10.08/sh10,000$100,8000 total
    Exercise: $14.92From: 2005-11-30Exp: 2015-05-14Common Shares (10,000 underlying)
  • Disposition to Issuer

    Director stock option (right to buy)

    2010-07-27$6.94/sh10,000$69,4000 total
    Exercise: $18.06Exp: 2016-06-29Common Shares (10,000 underlying)
Footnotes (4)
  • [F1]The option vested in five equal annual installments beginning on 6/29/07 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010
  • [F2]The option vested in five equal annual installments beginning on 6/13/08 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010
  • [F3]The option vested in five equal annual installments beginning on 4/10/09 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010
  • [F4]The option vested in five equal annual installments beginning on 4/23/10 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010

Issuer

SOMANETICS CORP

CIK 0000704328

Entity typeother

Related Parties

1
  • filerCIK 0001245082

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 1:13 PM ET
Size
18.2 KB